Skip to main content
Clinical Trials/JPRN-UMIN000006994
JPRN-UMIN000006994
Completed
Phase 2

Phase II trial of neoadjuvant chemotherapy for unresectable liver metastasis of colorectal cancer - TAMA conversion trial (TAC trial)

Surgery, Kyorin university hospital0 sites10 target enrollmentJanuary 1, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Colorectal cancer patients with unresectable liver metastasis
Sponsor
Surgery, Kyorin university hospital
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This clinical trial was discontinued due to a lack of case accumulation.

Registry
who.int
Start Date
January 1, 2012
End Date
March 31, 2017
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Surgery, Kyorin university hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with previous histories of severe drug hypersensitivity or drug allergies 2\) Patients with multiple primaries 3\) Patients with metastasis outside the liver and regional lymph nodes 4\) Patients with infection (fever of 38 degrees C or over) 5\) Patients with severe comobidities (interstitial pneumonia or pulmonary fibrosis, cardiac failure, renal failure, liver failure, uncontrollable diabetes or hypertension, jaundice) 6\) Patients with pleural effusion or ascites requiring treatment 7\) Patients with diarrhea (watery) 8\) Patients receiving atazanavir sulfate or flucytosine treatment 9\) Pregnant women and women suspected of being pregnant and lactating women 10\) Patients evaluated as unsuitable for this trial by the doctor in charge 11\) Patients with arterial or venous thrombosis in KRAS mutant cases

Outcomes

Primary Outcomes

Not specified

Similar Trials